BOTHELL, Wash., Nov. 3 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (Amex: DDD) today announced that the Company will present at the Rodman & Renshaw 10th Annual Healthcare Conference to be held on November 10-12 at the New York Palace Hotel in New York City.
Daniel O. Wilds, SCOLR Pharma's President and CEO, is scheduled to present an overview of the Company's operations on Tuesday, November 11, 2008 at 12:00 p.m. ET. For more information please visit the conference website: http://www.rodm.com/conferences?id=19.
About SCOLR Pharma
Based in Bothell, Washington, SCOLR Pharma, Inc. is a specialty
pharmaceutical company. SCOLR Pharma's corporate objective is to combine
its formulation expertise and its patented CDT platform to develop novel
pharmaceutical, over-the-counter (OTC), and nutritional products. Our CDT
drug delivery platform is based on multiple issued and pending patents and
other intellectual property for the programmed release or enhanced
performance of active pharmaceutical ingredients and nutritional products.
For more information on SCOLR Pharma, please call 425.368.1050 or visit
|SOURCE SCOLR Pharma, Inc.|
Copyright©2008 PR Newswire.
All rights reserved